Pantoprazole Bluefish 40 mg gastro-resistant tablets
Authorisation PA1436/008/002 · Bluefish Pharmaceuticals AB
- Licence holder
- Bluefish Pharmaceuticals AB (all products →)
- Active substance
- Pantoprazole sodium sesquihydrate
- Dosage form
- Gastro-resistant tablet
- Route of administration
- Oral use
- ATC codes
- A02BC, A02BC02
- First authorised
- 03/12/2010
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Pantoprazole sodium sesquihydrate: supply and approvals
13 authorised products on the HPRA list contain Pantoprazole sodium sesquihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 21 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 21 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 21 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 15 years (since 3 December 2010). The HPRA list marks it as marketed in Ireland.
Other medicines with Pantoprazole sodium sesquihydrate in Ireland
12 other products on the HPRA list contain Pantoprazole sodium sesquihydrate, from 8 licence holders; 8 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Pantium 20 mg gastro-resistant tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Pantium 40mg Gastro-Resistant Tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Pantoprazole Azevedos 40 mg powder for solution for injection/infusion | Laboratorios Azevedos Industria Farmaceutica S.A. | National authorisation (PA) | Marketed |
| Pantoprazole Bluefish 20 mg gastro-resistant tablets | Bluefish Pharmaceuticals AB | National authorisation (PA) | Marketed |
| Pantoprazole Teva Pharma 20 mg gastro-resistant tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Protium 20 mg gastro-resistant tablets | Takeda Products Ireland Ltd | National authorisation (PA) | Marketed |
| Protizole 20 mg gastro-resistant tablet | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| Protizole 40 mg gastro-resistant tablet | Accord Healthcare Ireland Ltd. | National authorisation (PA) | Marketed |
| CONTROLOC Control 20 mg Gastro-resistant tablet | Takeda GmbH | Centralised EU authorisation | Not stated |
| PANTOZOL Control 20 mg Gastro-resistant tablet | Takeda GmbH | Centralised EU authorisation | Not stated |
| Pantoprazole 40 mg powder for solution for injection | AS Kalceks | National authorisation (PA) | Not marketed |
| SOMAC Control 20 mg Gastro-resistant tablet | Takeda GmbH | Centralised EU authorisation | Not stated |
Other substances in ATC group A02BC
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 8 other active substances share the group A02BC with this product:
Omeprazole (17) · Lansoprazole (15) · Esomeprazole (14) · Pantoprazole (11) · Rabeprazole sodium (6) · Esomeprazole magnesium trihydrate (5) · Omeprazole magnesium (4) · Esomeprazole magnesium dihydrate (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Bluefish Pharmaceuticals AB holds 53 products on the HPRA list, with 24 different active substances; 40 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.